Literature DB >> 26876057

Mesalamine-induced myopericarditis - A case report.

Sónia Bernardo1, Samuel Raimundo Fernandes2, Luís Araújo-Correia1.   

Abstract

Myopericarditis has occasionally been reported as a side effect of mesalamine in patients with inflammatory bowel disease. We present a 20-year-old woman with ulcerative colitis admitted with chest pain. After thorough investigation she was diagnosed with myopericarditis potentially related to mesalamine. There was complete clinical and laboratorial recovery following drug withdrawal. Although uncommon, the possibility of myopericarditis should be considered in patients with inflammatory bowel disease presenting with cardiac complaints. Early recognition can avoid potential life-threatening complications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26876057     DOI: 10.17235/reed.2016.4016/2015

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  1 in total

Review 1.  Cardiovascular Manifestations in Inflammatory Bowel Disease: A Systematic Review of the Pathogenesis and Management of Pericarditis.

Authors:  Ravi S Patel; Sai Rohit Reddy; Adiona Llukmani; Ayat Hashim; Dana R Haddad; Dutt S Patel; Farrukh Ahmad; Domonick K Gordon
Journal:  Cureus       Date:  2021-03-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.